MSB 2022 - The road to commercialisation, page-671

  1. 920 Posts.
    lightbulb Created with Sketch. 429
    how i see it
    control groups are either standard of care or placebo.

    hyaluronic acid is not the current standard of care. it is experimental.

    msb is developing a new experimental therapy using cells with HA.

    they have done their research and it was found
    benefits of cells plus HA, over cells alone in our phase 3 results.

    benefit of cells vs HA alone, from phase 2. fda agrees

    this article is informative on the potential for msc and other compositions with HA for disc disease
    https://hotcopper.com.au/data/attachments/4328/4328224-22d9f3cef5a343faceb3cb11ff38cbe1.jpg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.67
Change
0.015(0.91%)
Mkt cap ! $2.133B
Open High Low Value Volume
$1.65 $1.67 $1.63 $3.655M 2.203M

Buyers (Bids)

No. Vol. Price($)
2 48000 $1.66
 

Sellers (Offers)

Price($) Vol. No.
$1.67 98565 7
View Market Depth
Last trade - 16.10pm 14/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.